Walter Schunack
About
In The Last Decade
Walter Schunack
331 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Biology 4.1k
- Immunology 4.0k
- Sensory Systems 1.5k
- Organic Chemistry 964
- Physiology 926
Countries citing papers authored by Walter Schunack
This map shows the geographic impact of Walter Schunack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Schunack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Schunack more than expected).
Fields of papers citing papers by Walter Schunack
This network shows the impact of papers produced by Walter Schunack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Schunack. The network helps show where Walter Schunack may publish in the future.
Co-authorship network of co-authors of Walter Schunack
This figure shows the co-authorship network connecting the top 25 collaborators of Walter Schunack. A scholar is included among the top collaborators of Walter Schunack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Schunack. Walter Schunack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length. | 3 |
| 3 | 15 | |
| 4 | 13 | |
| 5 | Radiosynthesis and biodistribution of two potential antagonists of cerebral histamine H3 receptors for PET studies: [18F]FUB 272 and [11C]UCL 1829 | 2 |
| 6 | 63 | |
| 7 | ヒスタミンH 3 受容器きっ抗薬に対する新しいリード構造の探索 アミン誘導体 | 4 |
| 8 | 12 | |
| 9 | 31 | |
| 10 | 40 | |
| 11 | 18 | |
| 12 | 39 | |
| 13 | 2 | |
| 14 | 12 | |
| 15 | Cardiohistaminergics - new developments in histamine H_2-agonists | 5 |
| 16 | 11 | |
| 17 | Halogenderivate von N-[3-(Imidazol-4-yl)propyl]-N'-(2-phenylthioalkyl)guanidinen | 1 |
| 18 | 29 | |
| 19 | Isohistamine und Homologe als Bausteine von H_2-Antagonisten | 3 |
| 20 | [Synthesis and H2-antihistaminic activity of ring methylated metiamide analogues. 4th communication: H2-antihistaminic agents (author's transl)]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.